Mapp Biopharmaceutical
Press Inquiries
  • About Us
  • Product Development
  • News
    • In the News
    • Press Releases
  • Publications
  • Job Openings
  • Contact Us

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease

October 18, 2022

BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin

November 24, 2020

PBS NewsHour – How to grow an Ebola vaccine with a tobacco plant

November 23, 2015

ZMapp™ is Granted Orphan Medicinal Product Designation by the EMA

October 15, 2015

ZMapp™ is Granted Fast Track Status by the FDA

September 17, 2015

Monoclonal Antibody-based Filovirus Therapeutic Licensed to Leaf Biopharmaceutical

July 15, 2014

Washington Post – The best innovations of 2014: ZMapp, for offering clues to a potential cure for Ebola

December 22, 2014

Status Update on ZMapp™

October 10, 2014

Consortium Wins Up to $28 Million from NIH to Find Best Proposed Ebola Treatment

March 20, 2014

International Joint Venture to Drive Commercialization of Filovirus Therapeutic via Monoclonal Antibodies

July 29, 2013

Recent News

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease

Oct 27, 2022

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease           To further enhance preparedness against health security threats, BARDA is extending a partnership with Mapp...

ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus

Oct 4, 2022

ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus     The Administration for Strategic Preparedness and Response (ASPR) today announced a $109.8 million contract with Mapp Biopharmaceutical Inc., for the advanced...

Additional Information

  • FCOI Policy
  • Purchase Order Terms and Conditions
  • Pay Transparency Nondiscrimination Provision
  • Equal Employment Opportunity is the Law
  • Institutional Biosafety Committee (NIH)
  • Employment of Individuals with Disabilities and Protected Veterans
  • Equal Employment Opportunity and Affirmative Action Policy Statement
  • Expanded Access Policy
Jobs Opportunities

© 2017-2022 Mapp Biopharmaceutical. All Rights Reserved.